adrenergic signaling
Recently Published Documents


TOTAL DOCUMENTS

390
(FIVE YEARS 71)

H-INDEX

46
(FIVE YEARS 6)

2021 ◽  
Author(s):  
Jennifer Batalla‐Covello ◽  
Shahrukh Ali ◽  
Tongxin Xie ◽  
Moran Amit

Life Sciences ◽  
2021 ◽  
pp. 120069
Author(s):  
Fabiane de Santi ◽  
Flávia L. Beltrame ◽  
Beatriz M. Rodrigues ◽  
Natália F. Scaramele ◽  
Flávia L. Lopes ◽  
...  

2021 ◽  
Vol 321 (4) ◽  
pp. H650-H662 ◽  
Author(s):  
Antonella Cellini ◽  
Dorina Höfler ◽  
Paula A. Arias-Loza ◽  
Sandra Bandleon ◽  
Tanja Langsenlehner ◽  
...  

Reduced systolic and diastolic calcium levels in cardiomyocytes from NKA-α2 transgenic mice minimize the desensitization of the β-adrenergic signaling system. These effects result in an improved β-adrenergic reserve and prevent functional deterioration and cardiac remodeling.


Author(s):  
X. Wang ◽  
P. Serrano Martinez ◽  
J.H. Terpstra ◽  
A. Shaalan ◽  
G.B. Proctor ◽  
...  

2021 ◽  
Vol 23 (3) ◽  
pp. 124-130
Author(s):  
Saeed Daneshyar ◽  
Mehdi Bahmani ◽  
Yazdan Fourotan

Background and aims: Beta-adrenergic signaling deficiency has been established to be related to obesity and related diseases. Beta3- adrenergic receptor (Adrb3) and beta-arrestin2 (Barr2) are pivotal agents in the beta-adrenergic-signaling pathway. This study aimed to investigate the preventive effect of aerobic training on dysregulation of Adrb3 and Barr2 gene expression that was induced by high-fat diet (HFD) in inguinal white adipose tissue of mice. Materials and Methods: Twenty-one C57BL/6 mice were assigned to three groups as follows: 1) control group (n=7), 2) high-fat diet-induced overweight (HFD-OW) (n=7), and 3) high-fat diet with aerobic training (HFD-AT) (n=7). The HFD-OW group were fed with a HFD for 12 weeks. The HFD-AT group had aerobic training for six weeks on a treadmill in addition to feeding with the HFD. The real-time polymerase chain reaction (PCR) method was used to measure the gene expression of Adrb3 and Barr2 in inguinal white adipose tissue. Results: The gene expression of Adrb3 did not significantly change between groups (P>0.05). However, the expression of Barr2 in HFD-OW group was significantly increased as compared to the control group (1.5-fold: P=0.001). Interestingly, the Barr2 expression in HFD-AT group was significantly lower compared with HFD-OW group (P=0.045). Conclusion: The results indicated that aerobic training could inhibit the upregulation of Barr2 induced by HFD. It seems that a portion of the preventive effect of aerobic training on the development of obesity may be mediated by inhibiting the Barr2 expression in adipose tissue.


2021 ◽  
Vol 35 (10) ◽  
Author(s):  
Itamar C. G. Jesus ◽  
Flávia M. Araújo ◽  
Thássio Mesquita ◽  
Nilton N. S. Júnior ◽  
Mário M. Silva ◽  
...  

2021 ◽  
Author(s):  
Alexander J Knights ◽  
Shanshan Liu ◽  
Yingxu Ma ◽  
Victoria S Nudell ◽  
Eric Perkey ◽  
...  

2021 ◽  
Author(s):  
Deborah Silverman ◽  
Sara Leahey ◽  
Shamima Akhter ◽  
Tongxin Xie ◽  
Yunfei Wang ◽  
...  

Cell Reports ◽  
2021 ◽  
Vol 36 (4) ◽  
pp. 109448
Author(s):  
Daniel Koch ◽  
Alexander Alexandrovich ◽  
Florian Funk ◽  
Ay Lin Kho ◽  
Joachim P. Schmitt ◽  
...  

2021 ◽  
Vol 22 (11) ◽  
pp. 6115
Author(s):  
Boris Mravec

Research on the neurobiology of cancer, which lies at the border of neuroscience and oncology, has elucidated the mechanisms and pathways that enable the nervous system to modulate processes associated with cancer initiation and progression. This research has also shown that several drugs which modulate interactions between the nervous system and the tumor micro- and macroenvironments significantly reduced the progression of cancer in animal models. Encouraging results were also provided by prospective clinical trials investigating the effect of drugs that reduce adrenergic signaling on the course of cancer in oncological patients. Moreover, it has been shown that reducing adrenergic signaling might also reduce the incidence of cancer in animal models, as well as in humans. However, even if many experimental and clinical findings have confirmed the preventive and therapeutic potential of drugs that reduce the stimulatory effect of the nervous system on processes related to cancer initiation and progression, several questions remain unanswered. Therefore, the aim of this review is to critically evaluate the efficiency of these drugs and to discuss questions that need to be answered before their introduction into conventional cancer treatment and prevention.


Sign in / Sign up

Export Citation Format

Share Document